Which has grown faster, INSP or NEO?

Over the past five years, INSP grew revenue faster — INSP at a 38.69% CAGR versus NEO at 9.41%.

Is INSP or NEO more profitable?

INSP runs the higher net margin — INSP at 15.03% versus NEO at -6.77%.

How have INSP and NEO total returns compared?

Over the past 5 years, INSP delivered -21.78% and NEO delivered -17.55% annualized total return. Past performance doesn't predict future results.

Inspire Medical Systems, Inc. (INSP) vs NeoGenomics, Inc. (NEO)

A side-by-side comparison of Inspire Medical Systems, Inc. and NeoGenomics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 4, 2026. Differences are shown without an overall score or investment verdict.

INSP

Inspire Medical Systems, Inc.

$2.02B

$69.97HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

NEO

NeoGenomics, Inc.

$475M

$18.47HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — INSP vs NEO

growth of $100 · dividends reinvested · last 8y

INSP +180.1% (+13.7%/yr)NEO +81.0% (+7.7%/yr)INSP compounded faster over this window

INSP NEO

INSP vs NEO: by the numbers

•INSP is the larger company ($2.02B vs $475M market cap).
•INSP is profitable (15.03% net margin) while NEO runs a net loss (-6.77%).
•INSP grew revenue faster over the past five years (38.69% vs 9.41% CAGR).

Metrics side by side

Valuation

Metric	INSP	NEO
P/E ratio	15.14	N/A
Forward P/E	58.58	101.08
P/S ratio	2.25	0.62
P/B ratio	2.45	0.60
EV / EBITDA	26.98	N/A
FCF yield	5.79%	N/A

Profitability

Metric	INSP	NEO
Gross margin	86.13%	42.92%
Operating margin	6.02%	-8.63%
Net margin	15.03%	-6.77%
ROE	16.36%	-6.60%
ROIC	6.33%	-5.29%

Growth (annualized)

Metric	INSP	NEO
Revenue CAGR (5Y)	38.69%	9.41%
Total return CAGR (5Y)	-21.78%	-17.55%

Frequently asked

Which has grown faster, INSP or NEO?: Over the past five years, INSP grew revenue faster — INSP at a 38.69% CAGR versus NEO at 9.41%.
Is INSP or NEO more profitable?: INSP runs the higher net margin — INSP at 15.03% versus NEO at -6.77%.
How have INSP and NEO total returns compared?: Over the past 5 years, INSP delivered -21.78% and NEO delivered -17.55% annualized total return. Past performance doesn't predict future results.

Go deeper

Full INSP analysis Full NEO analysis Interactive comparison tool

Dig into the metrics

Inspire Medical Systems P/E ratio Inspire Medical Systems ROE NeoGenomics ROE Inspire Medical Systems operating margin NeoGenomics operating margin Inspire Medical Systems revenue growth NeoGenomics revenue growth Inspire Medical Systems free cash flow NeoGenomics free cash flow

Inspire Medical Systems & NeoGenomics appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 4, 2026.